...
首页> 外文期刊>Anti-cancer drugs >Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
【24h】

Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.

机译:高细胞密度对肿瘤细胞生长特性的影响:在化学治疗药物的肿瘤细胞毒性中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to understand the role of tumor progression in the growth properties of tumor cells and their susceptibility to the cytotoxicity of chemotherapeutic drugs. A murine transplantable T cell lymphoma of spontaneous origin, designated as Dalton's lymphoma, was used as a model tumor for this investigation. Tumor cells were harvested from the early (5 days after tumor transplantation) and late tumor-bearing stages (17 days after tumor transplantation), with or without in-vivo administration of the chemotherapeutic drugs, cisplatin or doxorubicin. Tumor cells harvested at the late tumor-bearing stages showed a higher proliferative ability in vitro. Tumor progression was found to be associated with a decline in the tumor cytotoxicity of the chemotherapeutic drugs. Similar results were also obtained when tumor cells were cultured at low (10(5) cells/ml) and high (10(9) cells/ml) cell densities in vitro in medium alone or in one containing the chemotherapeutic drugs. An increase in the expression of heat shock protein (Hsp70), vascular endothelial growth factor, interleukin-2 receptor and interleukin-2 proteins along with an inhibition in the expression of caspase-activated DNase and p53 proteins was observed during the late tumor-bearing stage and also in the Dalton's lymphoma cells when cultured in vitro at a higher cell density. The ascitic fluid obtained from the late tumor-bearing stage and the culture supernatant of tumor cells incubated in vitro at high cell density showed high levels of cell growth-regulating cytokines: interleukin-1, interleukin-2, interferon-gamma, vascular endothelial growth factor, tumor growth factor-beta and interleukin-10. In-vivo administration of cisplatin in tumor-bearing mice at the late tumor-bearing stage did not alter the level of these cytokines in the ascitic fluid. In view of the results of this investigation, it is suggested that under high cellular density-associated environmental conditions the tumor cells alter their growth properties depending on an alteration in the expression of cell growth and apoptosis-regulating proteins. Tumor cells, thus, switch to a high level of proliferation, which renders them resistant to the cytotoxicity of chemotherapeutic drugs.
机译:这项研究的目的是了解肿瘤进展在肿瘤细胞生长特性中的作用以及它们对化学治疗药物的细胞毒性的敏感性。鼠源性自发的可移植T细胞淋巴瘤被称为道尔顿淋巴瘤,被用作该研究的模型肿瘤。在有或没有体内施用化学治疗药物,顺铂或阿霉素的情况下,从早期(肿瘤移植后5天)和肿瘤晚期(肿瘤移植后17天)收获肿瘤细胞。在荷瘤晚期阶段收获的肿瘤细胞在体外显示出更高的增殖能力。发现肿瘤的进展与化学治疗药物的肿瘤细胞毒性的下降有关。当在单独的培养基或含化学治疗药物的培养基中以低(10(5)细胞/ ml)和高(10(9)细胞/ ml)细胞密度体外培养肿瘤细胞时,也获得了相似的结果。肿瘤晚期发现热休克蛋白(Hsp70),血管内皮生长因子,白介素2受体和白介素2蛋白的表达增加,同时caspase激活的DNase和p53蛋白的表达受到抑制。在体外以较高的细胞密度培养时,在道尔顿淋巴瘤细胞中也是如此。从晚期肿瘤获得的腹水和在高细胞密度下体外培养的肿瘤细胞的培养上清液显示出高水平的细胞生长调节细胞因子:白介素-1,白介素-2,干扰素-γ,血管内皮生长因子,肿瘤生长因子β和白介素10。在荷瘤晚期,在荷瘤小鼠体内给予顺铂不会改变腹水中这些细胞因子的水平。鉴于这项研究的结果,建议在高细胞密度相关的环境条件下,肿瘤细胞根据细胞生长和凋亡调节蛋白的表达变化来改变其生长特性。因此,肿瘤细胞转变为高水平的增殖,这使其对化学治疗药物的细胞毒性具有抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号